BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19273609)

  • 1. Tyrosine phosphorylation of Grb2: role in prolactin/epidermal growth factor cross talk in mammary epithelial cell growth and differentiation.
    Haines E; Minoo P; Feng Z; Resalatpanah N; Nie XM; Campiglio M; Alvarez L; Cocolakis E; Ridha M; Di Fulvio M; Gomez-Cambronero J; Lebrun JJ; Ali S
    Mol Cell Biol; 2009 May; 29(10):2505-20. PubMed ID: 19273609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin and ErbB4/HER4 signaling interact via Janus kinase 2 to induce mammary epithelial cell gene expression differentiation.
    Muraoka-Cook RS; Sandahl M; Hunter D; Miraglia L; Earp HS
    Mol Endocrinol; 2008 Oct; 22(10):2307-21. PubMed ID: 18653779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin inhibits epidermal growth factor-induced Ras-MAPK signaling in mammary epithelial cells.
    Johnson JL; Fenton S; Sheffield LG
    J Biol Chem; 1996 Aug; 271(35):21574-8. PubMed ID: 8702944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer.
    Yamauchi T; Yamauchi N; Ueki K; Sugiyama T; Waki H; Miki H; Tobe K; Matsuda S; Tsushima T; Yamamoto T; Fujita T; Taketani Y; Fukayama M; Kimura S; Yazaki Y; Nagai R; Kadowaki T
    J Biol Chem; 2000 Oct; 275(43):33937-44. PubMed ID: 10938266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.
    Pauloin A; Chanat E
    Biochim Biophys Acta; 2012 May; 1823(5):987-96. PubMed ID: 22426621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative Ras enhances lactogenic hormone-induced differentiation by blocking activation of the Raf-Mek-Erk signal transduction pathway.
    Cerrito MG; Galbaugh T; Wang W; Chopp T; Salomon D; Cutler ML
    J Cell Physiol; 2004 Nov; 201(2):244-58. PubMed ID: 15334659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS; Brim H; Sherif ZA
    Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.
    Das R; Vonderhaar BK
    Oncogene; 1996 Sep; 13(6):1139-45. PubMed ID: 8808687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.
    Yang X; Meyer K; Friedl A
    J Biol Chem; 2013 Jul; 288(29):21184-21196. PubMed ID: 23729680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.
    Qian L; Lopez V; Seo YA; Kelleher SL
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C369-77. PubMed ID: 19494234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
    Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
    PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG; Omi E; Gibori G; Rao MC
    Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N; Matsuda T
    J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
    Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
    Horsch K; Schaller MD; Hynes NE
    Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
    Kavarthapu R; Tsai Morris CH; Dufau ML
    Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
    Vacca F; Bagnato A; Catt KJ; Tecce R
    Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.